Trial Profile
Study of regorafenib in metastatic colorectal cancer patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2016
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Aug 2016 New trial record